Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
16.83 (1y: -18%)
Market Cap 716.7 M P/E(ttm)
Enterprise Value 781.32 M P/B 1.60
TRNX- NAS (USA)
Tornier B.V.
Not Rated
Top Ranked Predictable Companies
$16.83
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyÂ’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry		 vs
history
Cash to Debt 0.259
TRNX's Cash to Debt is ranked lower than
68% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3750.67 vs. TRNX: 0.259 )
TRNX' s 10-Year Cash to Debt Range
Min: 0.18   Max: 1.37
Current: 0.26
0.18
1.37
Equity to Asset 0.107
TRNX's Equity to Asset is ranked lower than
68% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.53 vs. TRNX: 0.107 )
TRNX' s 10-Year Equity to Asset Range
Min: -0.08   Max: 0.34
Current: 0.11
-0.08
0.34
F-Score: 3
Z-Score: 1.79
M-Score: -2.85
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyÂ’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry		 vs
history
Operating margin (%) -10.20
TRNX's Operating margin (%) is ranked lower than
72% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. TRNX: -10.20 )
TRNX' s 10-Year Operating margin (%) Range
Min: -16.1   Max: -2.7
Current: -10.2
-16.1
-2.7
Net-margin (%) -7.8
TRNX's Net-margin (%) is ranked lower than
72% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.25 vs. TRNX: -7.8 )
TRNX' s 10-Year Net-margin (%) Range
Min: -27.1   Max: -7.8
Current: -7.8
-27.1
-7.8
ROE (%) -5
TRNX's ROE (%) is ranked lower than
68% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 4.80 vs. TRNX: -5 )
TRNX' s 10-Year ROE (%) Range
Min: -24.9   Max: -5
Current: -5
-24.9
-5
ROA (%) -3.3
TRNX's ROA (%) is ranked lower than
70% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. TRNX: -3.3 )
TRNX' s 10-Year ROA (%) Range
Min: -10.5   Max: -3.3
Current: -3.3
-10.5
-3.3
ROC (Joel Greenblatt) (%) -19.20
TRNX's ROC (Joel Greenblatt) (%) is ranked lower than
68% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 14.00 vs. TRNX: -19.20 )
TRNX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -20.5   Max: -4
Current: -19.2
-20.5
-4
» TRNX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

TRNX Guru Trades in Q2 2012

Steven Cohen 157,903 sh (+81.08%)
» More
Q3 2012

TRNX Guru Trades in Q3 2012

Steven Cohen 557,347 sh (+252.97%)
» More
Q4 2012

TRNX Guru Trades in Q4 2012

Steven Cohen 647,351 sh (+16.15%)
» More
Q1 2013

TRNX Guru Trades in Q1 2013

Paul Tudor Jones 400,000 sh (New)
Steven Cohen 700,226 sh (+8.17%)
» More
» Details

Insider Trades

Latest Guru Trades with TRNX



No Insider Trades Found!

Ratios

vs
industry		 vs
history
P/B 1.60
TRNX's P/B is ranked higher than
61% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. TRNX: 1.60 )
TRNX' s 10-Year P/B Range
Min: 1.54   Max: 2.66
Current: 1.6
1.54
2.66
P/S 2.40
TRNX's P/S is ranked lower than
64% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. TRNX: 2.40 )
TRNX' s 10-Year P/S Range
Min: 2.34   Max: 6.78
Current: 2.4
2.34
6.78
EV-to-EBIT 500
TRNX's EV-to-EBIT is ranked lower than
66% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 16.25 vs. TRNX: 500 )
TRNX' s 10-Year EV-to-EBIT Range
Min: 641.6   Max: 1265.7
Current: 500
641.6
1265.7

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 8.9
TRNX's Price/Net Current Asset Value is ranked higher than
76% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 8.90 vs. TRNX: 8.9 )
TRNX' s 10-Year Price/Net Current Asset Value Range
Min: 8.4   Max: 9.4
Current: 8.9
8.4
9.4
Price/Tangible Book 10.1
TRNX's Price/Tangible Book is ranked higher than
74% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. TRNX: 10.1 )
TRNX' s 10-Year Price/Tangible Book Range
Min: 4   Max: 9.6
Current: 10.1
4
9.6
Price/Median PS Value 0.8
TRNX's Price/Median PS Value is ranked higher than
73% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. TRNX: 0.8 )
TRNX' s 10-Year Price/Median PS Value Range
Min: 0.8   Max: 0.9
Current: 0.8
0.8
0.9
Earnings Yield (Greenblatt) 0.20
TRNX's Earnings Yield (Greenblatt) is ranked higher than
55% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.95 vs. TRNX: 0.20 )
TRNX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 0.2
Current: 0.2
0.1
0.2

Business Description

Tornier N.V. operates as a medical device company offering products that treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The Company's products are organized in four major categories: upper extremity joints and trauma, lower extremity joints and trauma, sports medicine and orthobiologics, and large joints and other. The upper extremity products include joint replacement and bone fixation devices for the shoulder, hand, wrist and elbow; lower extremity products include joint replacement and bone fixation devices for the foot and ankle; sports medicine and orthobiologics product category includes products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries; and large joints and other products include hip and knee joint replacement implants and ancillary products. Tornier N.V. is based in Amsterdam, The Netherlands.
Company Website
Industry: Medical Devices
Compare:
Traded in other countries:T98.Germany

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial